Skip to content
2000
Volume 16, Issue 1
  • ISSN: 2667-3878
  • E-ISSN: 2667-3886

Abstract

Shikonin and its derivatives are excellent representatives of biologically active naphthoquinones. A wide range of investigations carried out in the last few decades validated their pharmacological efficacy. Besides having magnificent therapeutic potential, shikonin and its derivatives suffer from various pharmacokinetic, toxicity, and stability issues like poor bioavailability, nephrotoxicity, photodegradation, etc. Recently, various research groups have developed an extensive range of formulations to tackle these issues to ease their path to clinical practice. The latest formulation approaches have been focused on exploiting the unique features of novel functional excipients, which in turn escalate the therapeutic effect of shikonin. Moreover, the codelivery approach in various drug delivery systems has been taken into consideration in a recent while to reduce toxicity associated with shikonin and its derivatives. This review sheds light on the essential reports and patents published related to the array of formulations containing shikonin and its derivatives.

Loading

Article metrics loading...

/content/journals/raddf/10.2174/2667387816666220302112201
2022-03-01
2024-11-14
Loading full text...

Full text loading...

/content/journals/raddf/10.2174/2667387816666220302112201
Loading

  • Article Type:
    Review Article
Keyword(s): anticancer; antimicrobial; nano formulations; patents; Shikonin; wound healing
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test